12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Edarbyclor azilsartan medoxomil/chlorthalidone regulatory update

Takeda said that within the first 8 months of this year, it submitted regulatory applications for azilsartan medoxomil/chlorthalidone in Taiwan, Thailand and Indonesia to...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >